JRKL Antibodies

Santa Cruz Biotechnology delivers a wide array of JRKL Antibodies for advanced research in molecular biology. JRKL Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Jumonji domain-containing protein 2A (JRKL) plays a critical role in gene regulation and chromatin remodeling, influencing cellular processes such as differentiation and development. JRKL's involvement in epigenetic modifications makes it a significant target for understanding various biological pathways and disease mechanisms. Research focusing on JRKL continues to reveal its potential implications in cancer and other disorders. Scientists can explore molecular interactions and cellular pathways through precise detection and analysis of JRKL expression patterns. Advanced visualization techniques enable researchers to track JRKL localization within cellular compartments. Multiple conjugation options, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), provide flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies for JRKL support researchers worldwide in advancing our understanding of fundamental biological processes and disease mechanisms.